HOME >> BIOLOGY >> NEWS
Media Invite: Dinner to award prize for Progress in Cancer Research

The National Foundation for Cancer Research (NFCR) announced a Dinner/Reception to honor Harold F. Dvorak, M.D., Mallinckrodt Professor of Pathology at Harvard Medical School and Chief of the Department of Pathology at Beth Israel Deaconess Medical Center. Dr. Dvorak has been awarded the inaugural Albert Szent-Gyrgyi Prize for Progress in Cancer Research. The Dinner/reception will take place immediately before the American Association for Cancer Research (AACR) annual meeting. All media are invited and encouraged to attend.

ADDITIONAL INFORMATION: The Szent-Gyrgyi Prize Committee selected Dr. Dvorak based on his breakthrough discovery of vascular permeability factor/vascular endothelial cell growth factor (VPF/VEGF) and that contribution that has led to a series of discoveries which both elucidated the mechanisms of angiogenesis as well as the development of antibodies and small molecule therapies to inhibit VEGF.

"Without Dr. Dvorak's fundamental discovery we would probably not have had the therapeutic agent bevacizumab which has had a tremendous impact on improving survival for patients with advanced colorectal cancer, breast cancer, non-cell lung cancer and renal cell carcinoma", stated Chairman of the Szent-Gyrgyi Prize Committee Dr. Daniel Von Hoff, Vice President of the Translational Genomics Research Institute in Phoenix. "In addition, other small molecules which inhibit VEGF have also shown outstanding clinical antitumor activity with dramatic therapeutic effects for patients worldwide."

"Dr. Dvorak's seminal discoveries in basic science have led to significant clinical benefits for cancer patients, perfectly fitting the unique criteria of the Albert Szent-Gyrgyi Prize for Progress in Cancer Research," said Sujuan Ba, Ph.D., NFCR Chief Scientific Officer and Co-Chair of the Szent-Gyrgyi Prize Committee. "Dr. Dvorak's key VPF/VEGF discovery paved the way for researchers to better understand the mechanisms involved in tumor a
'"/>

Contact: Silas Deane
sdeane@nfcr.org
616-319-6007
National Foundation for Cancer Research
31-Mar-2006


Page: 1 2 3 4

Related biology news :

1. Media events planned for 2007 American Society of Gene Therapy meeting, May 30-June 3
2. Porous Media and its Applications in Science, Engineering and Industry
3. Media registration now open for special nanotechnology tour Sept. 12 in San Francisco
4. Media advisory: International mercury conference coming to Madison Aug. 6-11
5. Bat Blitz: Media invited to learn about bats in the southeast
6. Media teleconference announces ocean acidification findings
7. Antarctic Treaty Meeting - Media opportunities
8. Media alert: New study finds dairy is not associated with weight gain
9. 2006 Ocean Sciences Meeting - Media advisory 1
10. Media alert A look forward and a look back: 50 years of crop science
11. Media alert: Special session on the impact of Hurricanes Katrina, Rita on crops, soils, environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology ... of its forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues ... and DNA analysis methods. The team has added experienced genealogists, each having over ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. ... automation and IT solutions for the life sciences industry, is pleased to announce the ... working out of the company’s Seabrook, New Hampshire office. In his new role, ...
(Date:6/5/2020)... ... , ... “Although we are disappointed to have to make this decision our ... public. We remain committed to creating a global platform to showcase the science, ... President of WMIS. , The abstract deadline for the virtual meeting ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem ... 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, ... die having some form of Alzheimers dementia, and the incidence continues to increase as ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
Breaking Biology Technology:
Cached News: